Structural basis of latent TGF-β1 presentation and activation by GARP on human regulatory T cells.
basic_science · Level V
Where this comes from
- Record sourced from PubMed, PMID 30361387.
- Also identified by DOI 10.1126/science.aau2909.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Transforming growth factor-β1 (TGF-β1) is one of very few cytokines produced in a latent form, requiring activation to exert any of its vastly diverse effects on development, immunity, and cancer. Regulatory T cells (T<sub>regs</sub>) suppress immune cells within close proximity by activating latent TGF-β1 presented by GARP (glycoprotein A repetitions predominant) to integrin αVβ8 on their surface. We solved the crystal structure of GARP:latent TGF-β1 bound to an antibody that stabilizes the complex and blocks release of active TGF-β1. This finding reveals how GARP exploits an unusual medley of interactions, including fold complementation by the amino terminus of TGF-β1, to chaperone and orient the cytokine for binding and activation by αVβ8. Thus, this work further elucidates the mechanism of antibody-mediated blockade of TGF-β1 activation and immunosuppression by T<sub>regs</sub>.
Medical subject headings
- Immune Tolerance
- Membrane Proteins
- T-Lymphocytes, Regulatory
- Transforming Growth Factor beta1